Market
Trace secures funding from Axogen for nerve imaging technology
Trace Biosciences received strategic funding from Axogen to develop Nerve Trace, a nerve-specific imaging technology. The investment supports advancement of the imaging platform, which targets nerve visualization applications relevant to surgical and diagnostic workflows.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network